ArticleProceedings of the National Academy of Sciences of the United States of America2022

Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression.

Yun-Song Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.